Virtus ETF Advisers’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,970	Closed	-$65.3K	–	421
2024 Q4	$65.3K	Sell	19,970 -9,192	-32%	-$33.8K	0.03%	418
2024 Q3	$112K	Buy	29,162 +515	+2%	+$1.98K	0.05%	359
2024 Q2	$88.5K	Buy	+28,647	New	+$85.9K	0.04%	366
2023 Q4	–	Sell	-40,040	Closed	-$81.3K	–	426
2023 Q3	$81.3K	Sell	40,040 -3,984	-9%	-$8.35K	0.05%	358
2023 Q2	$101K	Buy	44,024 +6,827	+18%	+$17.8K	0.06%	374
2023 Q1	$113K	Sell	37,197 -14,299	-28%	-$40.3K	0.06%	329
2022 Q4	$120K	Buy	51,496 +8,508	+20%	+$20.4K	0.06%	416
2022 Q3	$82K	Buy	42,988 +313	+0.7%	+$737	0.03%	427
2022 Q2	$116K	Buy	42,675 +5,227	+14%	+$13.4K	0.04%	394
2022 Q1	$112K	Sell	37,448 -2,227	-6%	-$6.82K	0.05%	283
2021 Q4	$154K	Buy	+39,675	New	+$154K	0.06%	340
2016 Q2	–	Sell	-54,471	Closed	-$225K	–	148
2016 Q1	$225K	Buy	+54,471	New	+$195K	0.31%	71